[Federal Register Volume 62, Number 215 (Thursday, November 6, 1997)] [Notices] [Page 60095] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-29359] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Cancer Institute Special Emphasis Panel (SEP) meetings: Name of SEP: Phase II Clinical Trails of New Chemopreventive Agents. Date: November 18, 1997. Time: 9:00 a.m. to adjournment. Place: Double Tree Hotel-Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Wilna Woods, Ph.D., Scientific Review Administrator, National Cancer Institute, NIH, Executive Plaza North, Room 622B, 6130 Executive Boulevard, MSC 7405, Bethesda, MD 20892-7405, Telephone: 301/496-7903. Purpose/Agenda: To review, discuss and evaluate responses to Request for Proposal. Name of SEP: Phase I Clinical Studies of Chemopreventive Agents. Date: November 29-20, 1997. Time: November 19-9:00 a.m. to recess; November 20-9:00 a.m. to adjournment. Place: Double Tree Hotel-Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Wilna Woods, Ph.D., Scientific Review Administrator, National Cancer Institute, NIH, Executive Plaza North, Room 622B, 6130 Executive Boulevard, MSC 7405, Bethesda, MD 20892-7405, Telephone: 301/496-7903. Purpose/Agenda: To review, discuss and evaluate responses to Request for Proposal. This notice is being published less than 15 days prior to the meeting due to the urgent need to meet timing limitations imposed by the review and funding cycle. The meetings will be closed in accordance with the provisions set for in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Program Numbers: 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control) Dated: October 30, 1997. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 97-29359 Filed 11-5-97; 8:45 am] BILLING CODE 4140-01-M